Home
Choose Language
Booking
News from the world
Utility & Other
Loyalty Program
Contact
Social & Multimedia
News | Financial Times (EN)
Condividi
post
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn
Scritto il 16/11/2026
da
Condividi
post
Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector